Click for best price

HIV Diagnostics Market Size, Share 2022

Market Analysis and Insights: Global HIV Diagnostics Market

The global HIV Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global HIV Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global HIV Diagnostics market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global HIV Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global HIV Diagnostics market.

Global HIV Diagnostics Scope and Market Size

HIV Diagnostics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global HIV Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2030.

Segment by Type

Consumables

Assay, Kits and Reagents

Other Consumables

Instruments

Software and Services

Segment by Application

Antibody Tests

Viral Load Tests

CD4 Tests

Tests for Early Infant Diagnosis

Tests for Viral Identification

By Region

North America

United States

Canada

Europe

Germany

France

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

By Company

Abbott

Abbott Healthcare

Abbvie Inc.

Brsitol-Myers Squibb

Janssen Therapeutics

Gilead Sciences

Merck & Co. Inc

VIIV Healthcare

BD Biosciences

Beckman Coulter

Partec

Sysmex

Apogee Flow Systems

PointCare Technologies Inc.

Zyomyx Inc.

Mylan inc.

Roche Diagnostics

Siemens Healthcare

Qiagen

BioMerieux

The information for each competitor/Company Profile includes:

Company Overview
Business Strategy
Key Product Offerings
Financial Performance
Key Performance Indicators
Risk Analysis
Recent Development
Regional Presence
SWOT Analysis

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes HIV Diagnostics product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of HIV Diagnostics, with price, sales, revenue, and global market share of HIV Diagnostics from 2019 to 2022.

Chapter 3, the HIV Diagnostics competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the HIV Diagnostics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the HIV Diagnostics market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of HIV Diagnostics.

Chapter 13, 14, and 15, to describe HIV Diagnostics sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

Estimates 2022-2027 2021-2025 HIV Diagnostics Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
Market dynamics scenario, along with growth opportunities of the market in the years to come
Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes	Report Details
Report Title	Global HIV Diagnostics Market Research Report 2023
Historical Year	2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year	2021
Forecast Year	2029
Number of Pages	110 Pages
Customization Available	Yes, the report can be customized as per your need.

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global HIV Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2030
1.2.2 Consumables
1.2.3 Assay, Kits and Reagents
1.2.4 Other Consumables
1.2.5 Instruments
1.2.6 Software and Services
1.3 Market by Application
1.3.1 Global HIV Diagnostics Market Share by Application: 2018 VS 2022 VS 2030
1.3.2 Antibody Tests
1.3.3 Viral Load Tests
1.3.4 CD4 Tests
1.3.5 Tests for Early Infant Diagnosis
1.3.6 Tests for Viral Identification
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global HIV Diagnostics Market Perspective (2018-2030)
2.2 HIV Diagnostics Growth Trends by Region
2.2.1 HIV Diagnostics Market Size by Region: 2018 VS 2022 VS 2030
2.2.2 HIV Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 HIV Diagnostics Forecasted Market Size by Region (2023-2030)
2.3 HIV Diagnostics Market Dynamics
2.3.1 HIV Diagnostics Industry Trends
2.3.2 HIV Diagnostics Market Drivers
2.3.3 HIV Diagnostics Market Challenges
2.3.4 HIV Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top HIV Diagnostics Players by Revenue
3.1.1 Global Top HIV Diagnostics Players by Revenue (2018-2023)
3.1.2 Global HIV Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global HIV Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by HIV Diagnostics Revenue
3.4 Global HIV Diagnostics Market Concentration Ratio
3.4.1 Global HIV Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by HIV Diagnostics Revenue in 2022
3.5 HIV Diagnostics Key Players Head office and Area Served
3.6 Key Players HIV Diagnostics Product Solution and Service
3.7 Date of Enter into HIV Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 HIV Diagnostics Breakdown Data by Type
4.1 Global HIV Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global HIV Diagnostics Forecasted Market Size by Type (2023-2030)
5 HIV Diagnostics Breakdown Data by Application
5.1 Global HIV Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global HIV Diagnostics Forecasted Market Size by Application (2023-2030)
6 North America
6.1 North America HIV Diagnostics Market Size (2018-2030)
6.2 North America HIV Diagnostics Market Size by Country (2018-2023)
6.3 North America HIV Diagnostics Market Size by Country (2023-2030)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe HIV Diagnostics Market Size (2018-2030)
7.2 Europe HIV Diagnostics Market Size by Country (2018-2023)
7.3 Europe HIV Diagnostics Market Size by Country (2023-2030)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific HIV Diagnostics Market Size (2018-2030)
8.2 Asia-Pacific HIV Diagnostics Market Size by Country (2018-2023)
8.3 Asia-Pacific HIV Diagnostics Market Size by Country (2023-2030)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America HIV Diagnostics Market Size (2018-2030)
9.2 Latin America HIV Diagnostics Market Size by Country (2018-2023)
9.3 Latin America HIV Diagnostics Market Size by Country (2023-2030)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa HIV Diagnostics Market Size (2018-2030)
10.2 Middle East & Africa HIV Diagnostics Market Size by Country (2018-2023)
10.3 Middle East & Africa HIV Diagnostics Market Size by Country (2023-2030)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott HIV Diagnostics Introduction
11.1.4 Abbott Revenue in HIV Diagnostics Business (2018-2023)
11.1.5 Abbott Recent Development
11.2 Abbott Healthcare
11.2.1 Abbott Healthcare Company Detail
11.2.2 Abbott Healthcare Business Overview
11.2.3 Abbott Healthcare HIV Diagnostics Introduction
11.2.4 Abbott Healthcare Revenue in HIV Diagnostics Business (2018-2023)
11.2.5 Abbott Healthcare Recent Development
11.3 Abbvie Inc.
11.3.1 Abbvie Inc. Company Detail
11.3.2 Abbvie Inc. Business Overview
11.3.3 Abbvie Inc. HIV Diagnostics Introduction
11.3.4 Abbvie Inc. Revenue in HIV Diagnostics Business (2018-2023)
11.3.5 Abbvie Inc. Recent Development
11.4 Brsitol-Myers Squibb
11.4.1 Brsitol-Myers Squibb Company Detail
11.4.2 Brsitol-Myers Squibb Business Overview
11.4.3 Brsitol-Myers Squibb HIV Diagnostics Introduction
11.4.4 Brsitol-Myers Squibb Revenue in HIV Diagnostics Business (2018-2023)
11.4.5 Brsitol-Myers Squibb Recent Development
11.5 Janssen Therapeutics
11.5.1 Janssen Therapeutics Company Detail
11.5.2 Janssen Therapeutics Business Overview
11.5.3 Janssen Therapeutics HIV Diagnostics Introduction
11.5.4 Janssen Therapeutics Revenue in HIV Diagnostics Business (2018-2023)
11.5.5 Janssen Therapeutics Recent Development
11.6 Gilead Sciences
11.6.1 Gilead Sciences Company Detail
11.6.2 Gilead Sciences Business Overview
11.6.3 Gilead Sciences HIV Diagnostics Introduction
11.6.4 Gilead Sciences Revenue in HIV Diagnostics Business (2018-2023)
11.6.5 Gilead Sciences Recent Development
11.7 Merck & Co. Inc
11.7.1 Merck & Co. Inc Company Detail
11.7.2 Merck & Co. Inc Business Overview
11.7.3 Merck & Co. Inc HIV Diagnostics Introduction
11.7.4 Merck & Co. Inc Revenue in HIV Diagnostics Business (2018-2023)
11.7.5 Merck & Co. Inc Recent Development
11.8 VIIV Healthcare
11.8.1 VIIV Healthcare Company Detail
11.8.2 VIIV Healthcare Business Overview
11.8.3 VIIV Healthcare HIV Diagnostics Introduction
11.8.4 VIIV Healthcare Revenue in HIV Diagnostics Business (2018-2023)
11.8.5 VIIV Healthcare Recent Development
11.9 BD Biosciences
11.9.1 BD Biosciences Company Detail
11.9.2 BD Biosciences Business Overview
11.9.3 BD Biosciences HIV Diagnostics Introduction
11.9.4 BD Biosciences Revenue in HIV Diagnostics Business (2018-2023)
11.9.5 BD Biosciences Recent Development
11.10 Beckman Coulter
11.10.1 Beckman Coulter Company Detail
11.10.2 Beckman Coulter Business Overview
11.10.3 Beckman Coulter HIV Diagnostics Introduction
11.10.4 Beckman Coulter Revenue in HIV Diagnostics Business (2018-2023)
11.10.5 Beckman Coulter Recent Development
11.11 Partec
11.11.1 Partec Company Detail
11.11.2 Partec Business Overview
11.11.3 Partec HIV Diagnostics Introduction
11.11.4 Partec Revenue in HIV Diagnostics Business (2018-2023)
11.11.5 Partec Recent Development
11.12 Sysmex
11.12.1 Sysmex Company Detail
11.12.2 Sysmex Business Overview
11.12.3 Sysmex HIV Diagnostics Introduction
11.12.4 Sysmex Revenue in HIV Diagnostics Business (2018-2023)
11.12.5 Sysmex Recent Development
11.13 Apogee Flow Systems
11.13.1 Apogee Flow Systems Company Detail
11.13.2 Apogee Flow Systems Business Overview
11.13.3 Apogee Flow Systems HIV Diagnostics Introduction
11.13.4 Apogee Flow Systems Revenue in HIV Diagnostics Business (2018-2023)
11.13.5 Apogee Flow Systems Recent Development
11.14 PointCare Technologies Inc.
11.14.1 PointCare Technologies Inc. Company Detail
11.14.2 PointCare Technologies Inc. Business Overview
11.14.3 PointCare Technologies Inc. HIV Diagnostics Introduction
11.14.4 PointCare Technologies Inc. Revenue in HIV Diagnostics Business (2018-2023)
11.14.5 PointCare Technologies Inc. Recent Development
11.15 Zyomyx Inc.
11.15.1 Zyomyx Inc. Company Detail
11.15.2 Zyomyx Inc. Business Overview
11.15.3 Zyomyx Inc. HIV Diagnostics Introduction
11.15.4 Zyomyx Inc. Revenue in HIV Diagnostics Business (2018-2023)
11.15.5 Zyomyx Inc. Recent Development
11.16 Mylan inc.
11.16.1 Mylan inc. Company Detail
11.16.2 Mylan inc. Business Overview
11.16.3 Mylan inc. HIV Diagnostics Introduction
11.16.4 Mylan inc. Revenue in HIV Diagnostics Business (2018-2023)
11.16.5 Mylan inc. Recent Development
11.17 Roche Diagnostics
11.17.1 Roche Diagnostics Company Detail
11.17.2 Roche Diagnostics Business Overview
11.17.3 Roche Diagnostics HIV Diagnostics Introduction
11.17.4 Roche Diagnostics Revenue in HIV Diagnostics Business (2018-2023)
11.17.5 Roche Diagnostics Recent Development
11.18 Siemens Healthcare
11.18.1 Siemens Healthcare Company Detail
11.18.2 Siemens Healthcare Business Overview
11.18.3 Siemens Healthcare HIV Diagnostics Introduction
11.18.4 Siemens Healthcare Revenue in HIV Diagnostics Business (2018-2023)
11.18.5 Siemens Healthcare Recent Development
11.19 Qiagen
11.19.1 Qiagen Company Detail
11.19.2 Qiagen Business Overview
11.19.3 Qiagen HIV Diagnostics Introduction
11.19.4 Qiagen Revenue in HIV Diagnostics Business (2018-2023)
11.19.5 Qiagen Recent Development
11.20 BioMerieux
11.20.1 BioMerieux Company Detail
11.20.2 BioMerieux Business Overview
11.20.3 BioMerieux HIV Diagnostics Introduction
11.20.4 BioMerieux Revenue in HIV Diagnostics Business (2018-2023)
11.20.5 BioMerieux Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global HIV Diagnostics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2030
Table 2. Key Players of Consumables
Table 3. Key Players of Assay, Kits and Reagents
Table 4. Key Players of Other Consumables
Table 5. Key Players of Instruments
Table 6. Key Players of Software and Services
Table 7. Global HIV Diagnostics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2030
Table 8. Global HIV Diagnostics Market Size by Region (US$ Million): 2018 VS 2022 VS 2030
Table 9. Global HIV Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global HIV Diagnostics Market Share by Region (2018-2023)
Table 11. Global HIV Diagnostics Forecasted Market Size by Region (2023-2030) & (US$ Million)
Table 12. Global HIV Diagnostics Market Share by Region (2023-2030)
Table 13. HIV Diagnostics Market Trends
Table 14. HIV Diagnostics Market Drivers
Table 15. HIV Diagnostics Market Challenges
Table 16. HIV Diagnostics Market Restraints
Table 17. Global HIV Diagnostics Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global HIV Diagnostics Market Share by Players (2018-2023)
Table 19. Global Top HIV Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Diagnostics as of 2022)
Table 20. Ranking of Global Top HIV Diagnostics Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by HIV Diagnostics Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players HIV Diagnostics Product Solution and Service
Table 24. Date of Enter into HIV Diagnostics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global HIV Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global HIV Diagnostics Revenue Market Share by Type (2018-2023)
Table 28. Global HIV Diagnostics Forecasted Market Size by Type (2023-2030) & (US$ Million)
Table 29. Global HIV Diagnostics Revenue Market Share by Type (2023-2030)
Table 30. Global HIV Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global HIV Diagnostics Revenue Market Share by Application (2018-2023)
Table 32. Global HIV Diagnostics Forecasted Market Size by Application (2023-2030) & (US$ Million)
Table 33. Global HIV Diagnostics Revenue Market Share by Application (2023-2030)
Table 34. North America HIV Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America HIV Diagnostics Market Size by Country (2023-2030) & (US$ Million)
Table 36. Europe HIV Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe HIV Diagnostics Market Size by Country (2023-2030) & (US$ Million)
Table 38. Asia-Pacific HIV Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific HIV Diagnostics Market Size by Region (2023-2030) & (US$ Million)
Table 40. Latin America HIV Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America HIV Diagnostics Market Size by Country (2023-2030) & (US$ Million)
Table 42. Middle East & Africa HIV Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 43. Middle East & Africa HIV Diagnostics Market Size by Country (2023-2030) & (US$ Million)
Table 44. Abbott Company Detail
Table 45. Abbott Business Overview
Table 46. Abbott HIV Diagnostics Product
Table 47. Abbott Revenue in HIV Diagnostics Business (2018-2023) & (US$ Million)
Table 48. Abbott Recent Development
Table 49. Abbott Healthcare Company Detail
Table 50. Abbott Healthcare Business Overview
Table 51. Abbott Healthcare HIV Diagnostics Product
Table 52. Abbott Healthcare Revenue in HIV Diagnostics Business (2018-2023) & (US$ Million)
Table 53. Abbott Healthcare Recent Development
Table 54. Abbvie Inc. Company Detail
Table 55. Abbvie Inc. Business Overview
Table 56. Abbvie Inc. HIV Diagnostics Product
Table 57. Abbvie Inc. Revenue in HIV Diagnostics Business (2018-2023) & (US$ Million)
Table 58. Abbvie Inc. Recent Development
Table 59. Brsitol-Myers Squibb Company Detail
Table 60. Brsitol-Myers Squibb Business Overview
Table 61. Brsitol-Myers Squibb HIV Diagnostics Product
Table 62. Brsitol-Myers Squibb Revenue in HIV Diagnostics Business (2018-2023) & (US$ Million)
Table 63. Brsitol-Myers Squibb Recent Development
Table 64. Janssen Therapeutics Company Detail
Table 65. Janssen Therapeutics Business Overview
Table 66. Janssen Therapeutics HIV Diagnostics Product
Table 67. Janssen Therapeutics Revenue in HIV Diagnostics Business (2018-2023) & (US$ Million)
Table 68. Janssen Therapeutics Recent Development
Table 69. Gilead Sciences Company Detail
Table 70. Gilead Sciences Business Overview
Table 71. Gilead Sciences HIV Diagnostics Product
Table 72. Gilead Sciences Revenue in HIV Diagnostics Business (2018-2023) & (US$ Million)
Table 73. Gilead Sciences Recent Development
Table 74. Merck & Co. Inc Company Detail
Table 75. Merck & Co. Inc Business Overview
Table 76. Merck & Co. Inc HIV Diagnostics Product
Table 77. Merck & Co. Inc Revenue in HIV Diagnostics Business (2018-2023) & (US$ Million)
Table 78. Merck & Co. Inc Recent Development
Table 79. VIIV Healthcare Company Detail
Table 80. VIIV Healthcare Business Overview
Table 81. VIIV Healthcare HIV Diagnostics Product
Table 82. VIIV Healthcare Revenue in HIV Diagnostics Business (2018-2023) & (US$ Million)
Table 83. VIIV Healthcare Recent Development
Table 84. BD Biosciences Company Detail
Table 85. BD Biosciences Business Overview
Table 86. BD Biosciences HIV Diagnostics Product
Table 87. BD Biosciences Revenue in HIV Diagnostics Business (2018-2023) & (US$ Million)
Table 88. BD Biosciences Recent Development
Table 89. Beckman Coulter Company Detail
Table 90. Beckman Coulter Business Overview
Table 91. Beckman Coulter HIV Diagnostics Product
Table 92. Beckman Coulter Revenue in HIV Diagnostics Business (2018-2023) & (US$ Million)
Table 93. Beckman Coulter Recent Development
Table 94. Partec Company Detail
Table 95. Partec Business Overview
Table 96. Partec HIV DiagnosticsProduct
Table 97. Partec Revenue in HIV Diagnostics Business (2018-2023) & (US$ Million)
Table 98. Partec Recent Development
Table 99. Sysmex Company Detail
Table 100. Sysmex Business Overview
Table 101. Sysmex HIV DiagnosticsProduct
Table 102. Sysmex Revenue in HIV Diagnostics Business (2018-2023) & (US$ Million)
Table 103. Sysmex Recent Development
Table 104. Apogee Flow Systems Company Detail
Table 105. Apogee Flow Systems Business Overview
Table 106. Apogee Flow Systems HIV DiagnosticsProduct
Table 107. Apogee Flow Systems Revenue in HIV Diagnostics Business (2018-2023) & (US$ Million)
Table 108. Apogee Flow Systems Recent Development
Table 109. PointCare Technologies Inc. Company Detail
Table 110. PointCare Technologies Inc. Business Overview
Table 111. PointCare Technologies Inc. HIV DiagnosticsProduct
Table 112. PointCare Technologies Inc. Revenue in HIV Diagnostics Business (2018-2023) & (US$ Million)
Table 113. PointCare Technologies Inc. Recent Development
Table 114. Zyomyx Inc. Company Detail
Table 115. Zyomyx Inc. Business Overview
Table 116. Zyomyx Inc. HIV DiagnosticsProduct
Table 117. Zyomyx Inc. Revenue in HIV Diagnostics Business (2018-2023) & (US$ Million)
Table 118. Zyomyx Inc. Recent Development
Table 119. Mylan inc. Company Detail
Table 120. Mylan inc. Business Overview
Table 121. Mylan inc. HIV DiagnosticsProduct
Table 122. Mylan inc. Revenue in HIV Diagnostics Business (2018-2023) & (US$ Million)
Table 123. Mylan inc. Recent Development
Table 124. Roche Diagnostics Company Detail
Table 125. Roche Diagnostics Business Overview
Table 126. Roche Diagnostics HIV DiagnosticsProduct
Table 127. Roche Diagnostics Revenue in HIV Diagnostics Business (2018-2023) & (US$ Million)
Table 128. Roche Diagnostics Recent Development
Table 129. Siemens Healthcare Company Detail
Table 130. Siemens Healthcare Business Overview
Table 131. Siemens Healthcare HIV DiagnosticsProduct
Table 132. Siemens Healthcare Revenue in HIV Diagnostics Business (2018-2023) & (US$ Million)
Table 133. Siemens Healthcare Recent Development
Table 134. Qiagen Company Detail
Table 135. Qiagen Business Overview
Table 136. Qiagen HIV DiagnosticsProduct
Table 137. Qiagen Revenue in HIV Diagnostics Business (2018-2023) & (US$ Million)
Table 138. Qiagen Recent Development
Table 139. BioMerieux Company Detail
Table 140. BioMerieux Business Overview
Table 141. BioMerieux HIV DiagnosticsProduct
Table 142. BioMerieux Revenue in HIV Diagnostics Business (2018-2023) & (US$ Million)
Table 143. BioMerieux Recent Development
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Global HIV Diagnostics Market Share by Type: 2022 VS 2030
Figure 2. Consumables Features
Figure 3. Assay, Kits and Reagents Features
Figure 4. Other Consumables Features
Figure 5. Instruments Features
Figure 6. Software and Services Features
Figure 7. Global HIV Diagnostics Market Share by Application in 2022 & 2030
Figure 8. Antibody Tests Case Studies
Figure 9. Viral Load Tests Case Studies
Figure 10. CD4 Tests Case Studies
Figure 11. Tests for Early Infant Diagnosis Case Studies
Figure 12. Tests for Viral Identification Case Studies
Figure 13. HIV Diagnostics Report Years Considered
Figure 14. Global HIV Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2030
Figure 15. Global HIV Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2030
Figure 16. Global HIV Diagnostics Market Share by Region: 2022 VS 2030
Figure 17. Global HIV Diagnostics Market Share by Players in 2022
Figure 18. Global Top HIV Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Diagnostics as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by HIV Diagnostics Revenue in 2022
Figure 20. North America HIV Diagnostics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 21. North America HIV Diagnostics Market Share by Country (2018-2030)
Figure 22. United States HIV Diagnostics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 23. Canada HIV Diagnostics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 24. Europe HIV Diagnostics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 25. Europe HIV Diagnostics Market Share by Country (2018-2030)
Figure 26. Germany HIV Diagnostics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 27. France HIV Diagnostics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 28. U.K. HIV Diagnostics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 29. Italy HIV Diagnostics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 30. Russia HIV Diagnostics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 31. Nordic Countries HIV Diagnostics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 32. Asia-Pacific HIV Diagnostics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 33. Asia-Pacific HIV Diagnostics Market Share by Region (2018-2030)
Figure 34. China HIV Diagnostics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 35. Japan HIV Diagnostics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 36. South Korea HIV Diagnostics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 37. Southeast Asia HIV Diagnostics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 38. India HIV Diagnostics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 39. Australia HIV Diagnostics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 40. Latin America HIV Diagnostics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 41. Latin America HIV Diagnostics Market Share by Country (2018-2030)
Figure 42. Mexico HIV Diagnostics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 43. Brazil HIV Diagnostics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 44. Middle East & Africa HIV Diagnostics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 45. Middle East & Africa HIV Diagnostics Market Share by Country (2018-2030)
Figure 46. Turkey HIV Diagnostics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 47. Saudi Arabia HIV Diagnostics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 48. Abbott Revenue Growth Rate in HIV Diagnostics Business (2018-2023)
Figure 49. Abbott Healthcare Revenue Growth Rate in HIV Diagnostics Business (2018-2023)
Figure 50. Abbvie Inc. Revenue Growth Rate in HIV Diagnostics Business (2018-2023)
Figure 51. Brsitol-Myers Squibb Revenue Growth Rate in HIV Diagnostics Business (2018-2023)
Figure 52. Janssen Therapeutics Revenue Growth Rate in HIV Diagnostics Business (2018-2023)
Figure 53. Gilead Sciences Revenue Growth Rate in HIV Diagnostics Business (2018-2023)
Figure 54. Merck & Co. Inc Revenue Growth Rate in HIV Diagnostics Business (2018-2023)
Figure 55. VIIV Healthcare Revenue Growth Rate in HIV Diagnostics Business (2018-2023)
Figure 56. BD Biosciences Revenue Growth Rate in HIV Diagnostics Business (2018-2023)
Figure 57. Beckman Coulter Revenue Growth Rate in HIV Diagnostics Business (2018-2023)
Figure 58. Partec Revenue Growth Rate in HIV Diagnostics Business (2018-2023)
Figure 59. Sysmex Revenue Growth Rate in HIV Diagnostics Business (2018-2023)
Figure 60. Apogee Flow Systems Revenue Growth Rate in HIV Diagnostics Business (2018-2023)
Figure 61. PointCare Technologies Inc. Revenue Growth Rate in HIV Diagnostics Business (2018-2023)
Figure 62. Zyomyx Inc. Revenue Growth Rate in HIV Diagnostics Business (2018-2023)
Figure 63. Mylan inc. Revenue Growth Rate in HIV Diagnostics Business (2018-2023)
Figure 64. Roche Diagnostics Revenue Growth Rate in HIV Diagnostics Business (2018-2023)
Figure 65. Siemens Healthcare Revenue Growth Rate in HIV Diagnostics Business (2018-2023)
Figure 66. Qiagen Revenue Growth Rate in HIV Diagnostics Business (2018-2023)
Figure 67. BioMerieux Revenue Growth Rate in HIV Diagnostics Business (2018-2023)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

DOWNLOAD SAMPLE

Download
Free Sample

Request
Customization

Check
Discount

REPORT PURCHASE OPTIONS

Single User Price : $2762

Multi User Price : $4143

Enterprise Price : $5524

---- OR ----

Frequently Asked Questions ?

Delivery Time

Upto 24 hrs - Working days
Upto 48 hrs max - Weekends and public holidays

User License

Single User License
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

Multi user License
A license granted to multiple users.

Site License
A license granted to a single business site/establishment.

Corporate License, Global License
A license granted to all employees within organisation access to the product.

Payment Options

Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer

Report Delivery

Email
Hard Copy

Our Key Features

Data Accuracy and Reliability
Data Security
Customized Research
Trustworthy
Competitive Offerings

Global HIV Diagnostics Market Research Report 2023